Aytu Biopharma, Inc (AYTU)

CIK 1385818 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aytu Biopharma, Inc.

Recent SEC filings

FiledFormAccession number
Oct 27, 2026DEFA14A0001437749-26-033652
Oct 22, 2026DEF 14A0001437749-26-033276
Sep 22, 20268-K0001437749-26-030900
Sep 22, 202610-K0001437749-26-030908
Aug 14, 2026SCHEDULE 13G/A0000935836-26-000405
Jul 30, 202640001437749-26-025075
Jul 30, 202640001437749-26-025077
Jul 30, 202640001437749-26-025082
Jul 30, 202640001437749-26-025081
Jul 30, 202640001437749-26-025076
Jul 30, 202640001437749-26-025083
Jul 30, 202640001437749-26-025080
Jul 30, 202640001437749-26-025078
Jun 25, 20268-K0001437749-26-021707
May 13, 20268-K0001437749-26-016717
May 13, 202610-Q0001437749-26-016721
Apr 2, 20268-K0001437749-26-011116
Feb 17, 2026SCHEDULE 13G/A0000935836-26-000109
Feb 13, 2026SCHEDULE 13G/A0001535264-26-000010
Feb 3, 202610-Q0001437749-26-002804
Feb 3, 20268-K0001437749-26-002799
Jan 20, 20268-K0001437749-26-001543
Dec 10, 20258-K0001437749-25-037389
Nov 14, 2025SCHEDULE 13G/A0000935836-25-000682
Nov 13, 202510-Q0001437749-25-034825